T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CFB
2651
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $105K | ﹤0.01% |
+10,327
| New | +$112K |
|
2652
Savara
SVRA
$1.11B
| $104K | ﹤0.01% |
27,320
-8,239
| -23% | -$29.4K |
|
2653
Aspen Aerogels
ASPN
$508M
| $103K | ﹤0.01% |
11,968
+1,280
| +12% | +$9.09K |
|
2654
MediaAlpha
MAX
$800M
| $103K | ﹤0.01% |
12,371
-2,795
| -18% | -$25K |
|
2655
Planet Labs
PL
$8.8B
| $103K | ﹤0.01% |
39,385
+695
| +2% | +$2.21K |
|
|
SUP
2656
DELISTED
Superior Industries International
SUP
| $103K | ﹤0.01% |
33,700
| – | – |
|
2657
Aveanna Healthcare
AVAH
$2.3B
| $102K | ﹤0.01% |
85,558
+3,640
| +4% | +$5.64K |
|
|
MCHB
2658
Mechanics Bancorp
MCHB
$3.81B
| $102K | ﹤0.01% |
13,092
+714
| +6% | +$6.34K |
|
2659
W&T Offshore
WTI
$546M
| $102K | ﹤0.01% |
23,222
+4,196
| +22% | +$17.3K |
|
2660
Lineage Cell Therapeutics
LCTX
$268M
| $101K | ﹤0.01% |
85,336
| – | – |
|
2661
ReposiTrak
TRAK
$154M
| $101K | ﹤0.01% |
+11,500
| New | +$106K |
|
2662
Alpha Pro Tech
APT
$55M
| $100K | ﹤0.01% |
22,900
| – | – |
|
2663
Citizens
CIA
$201M
| $100K | ﹤0.01% |
34,900
-9,600
| -22% | -$27.4K |
|
|
YMAB
2664
DELISTED
Y-mAbs Therapeutics
YMAB
| $100K | ﹤0.01% |
18,282
| – | – |
|
|
KG
2665
Kestrel Group
KG
$66.8M
| $99K | ﹤0.01% |
2,803
+815
| +41% | +$30.2K |
|
2666
Applied Digital
APLD
$9B
| $97K | ﹤0.01% |
15,501
+1,370
| +10% | +$9.57K |
|
2667
Rackspace Technology
RXT
$1.1B
| $97K | ﹤0.01% |
41,215
| – | – |
|
2668
Teekay
TK
$1.07B
| $97K | ﹤0.01% |
15,691
+2,294
| +17% | +$14.6K |
|
|
TSVT
2669
DELISTED
2seventy bio
TSVT
| $97K | ﹤0.01% |
24,554
+4,626
| +23% | +$30.3K |
|
2670
Clarus
CLAR
$143M
| $96K | ﹤0.01% |
12,588
+902
| +8% | +$7.23K |
|
2671
Lands' End
LE
$394M
| $94K | ﹤0.01% |
12,515
+469
| +4% | +$3.99K |
|
|
QVCGA
2672
DELISTED
QVC Group Inc Series A
QVCGA
| $94K | ﹤0.01% |
3,095
| – | – |
|
2673
Stereotaxis
STXS
$137M
| $93K | ﹤0.01% |
58,400
| – | – |
|
2674
Kartoon Studios
TOON
$38.7M
| $93K | ﹤0.01% |
66,240
+14,400
| +28% | +$25.6K |
|
|
KLRS
2675
Kalaris Therapeutics
KLRS
$92.4M
| $93K | ﹤0.01% |
1,873
+605
| +48% | +$41.2K |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.